Kircher DA, Trombetti KA, Silvis MR, Parkman GL, Fischer GM, Angel SN, Stehn CM, Strain SC, Grossmann AH, Duffy KL, Boucher KM, McMahon M, Davies MA , Mendoza MC, VanBrocklin MW, Holmen SL
Research indicates that irritable bowel syndrome, intestinal motility disorders, and chronic pancreatitis are the most common conditions associated with SIBO, accounting for 80-90% of cases
Evidence grade Moderate (8/10) The GLP-1 semaglutide (#Ozempic) failed to improve mood and executive functioning in this, the first RCT of a GLP-1 for major #depression: sciencedirect.com/science/articl Weight loss was significant (all subjects were overweight/obese)
administered 15 min before oral injection of d-allulose
Metabolites 12 (4), 352
These actions help regulate appetite, increase feelings of fullness, and support healthier eating patterns